Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction

BACKGROUND AND AIMS: Sodium–glucose linked cotransporter-2 (SGLT2) inhibitors reduce the likelihood of hospitalization for heart failure and cardiovascular death in both diabetic and non-diabetic individuals with reduced ejection fraction heart failure. Because SGLT2 inhibitors lead to volume contra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cardiovasc Diabetol
Autores principales: Connelly, Kim A., Zhang, Yanling, Desjardins, Jean-François, Nghiem, Linda, Visram, Aylin, Batchu, Sri N., Yerra, Verra G., Kabir, Golam, Thai, Kerri, Advani, Andrew, Gilbert, Richard E.
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007658/
https://ncbi.nlm.nih.gov/pubmed/32035482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-020-0994-y
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares